16
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A study of aromatic nitro compounds for the selection of candidates for carcinogen bioassay

, , , , &
Pages 75-128 | Published online: 15 Dec 2008
 

Abstract

The class of aromatic nitro compounds was studied in order to nominate chemicals to the National Cancer Institute as candidates for carcinogen bioassay. After application of several qualifying criteria relating to previous, current, or planned carcinogenicity tests and to commercial significance, the preliminary candidate list of 441 chemicals was reduced to a list of 210 chemicals. Based upon consideration of both the suspicion of possible carcinogenic activity and evidence indicating potential exposure, the following 14 chemicals were nominated: 4‐chloro‐2‐nitroaniline; 2,4‐dinitroaniline; 4‐nitroaniline; benefin; 2‐bromo‐4,6‐dinitro‐aniline; 2‐nitroanisole; nitrobenzene; 4,4'‐dinitro‐2,2'‐stilbene‐disulfonic acid; l,8‐dihydroxy‐4,5‐dinitroanthraquinone; C.I. Pigment Red 3; C.I. Pigment Orange 5; C.I. Pigment Red 23; C.I. Pigment Yellow 74; and 2‐amino‐6‐nitrobenzothiazole.

Notes

Reprints may be obtained from C.T. Helmes and also from Dr. H. F. Kraybill, Scientific Coordinator for the Office of Environmental Cancer, Division of Cancer Cause and Prevention, National Cancer Institute, Landow Building, Room C337, 7910 Woodmont Avenue, Bethesda, Maryland 20205

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.